TSR-011
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TSR-011, covering 2019-03-26 to 2019-03-26. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas [Phase 1, Phase 2]